Table 2 Corresponding concentrations of FA+DDSdox+ and GNPdox+:FA+DDSdox+ containing equimolar doxorubicin concentration selected for the study.

From: Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex

S. No.

Conc. of doxorubicin selected for toxicity study (μM)

Equimolar Conc. of FA+DDSdox+ (μM)

Equimolar Concn. of GNP dox+-FA+DDSdox+ (μM)

1

0.5

0.038

0.016

2

1.0

0.070

0.030

3

2.0

0.190

0.060

4

3.0

0.210

0.090

5

3.6

0.252

0.108

6

4.0

0.280

0.120

Back to article page